Labour market · 31/08/1999Updated: 10/17/2026 · 1 min read

Timken Company Reconsiders Determination Regarding Application for Reconsideration

Summary

The Timken Company, a leading manufacturer based in Canton, Ohio, has issued a notice regarding the reconsideration of a previously made determination. The company is seeking to affirm its previous decision, which was made in response to an application filed by Timken.

Original source language: Federal Register — Department of LaborOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Labour market · 10/22/2026

Tairex launched a multi-agent AI system to transform the collaboration clinique and help in decision making.

PÉKIN, 22 October 2026 — On 21 October, Tairex, a health technology society based on AI incubated by the Institute for AI Industry Research (AIR) of Tsinghua University, unveiled an ecosystem...

Read summary →

Labour market · 10/22/2026

Georgiamune and the Menarini Group conclude an exclusive global licensing and collaboration agreement on GIM-621, an innovative oral immuno-oncological agent

GIM-621 is an innovative, preclinical, small molecule oral immunotherapy that has potential for application in the treatment of several solid tumours.

Read summary →

Labour market · 10/22/2026

Barclays cutting 5,000 jobs as it increases reliance on AI

The bank says it is using more AI leading to a 5% reduction in its workforce.

Read summary →

Labour market · 10/22/2026

Georgiamune and Menarini Group enter into an exclusive global license and collaboration agreement for GIM-621, a first-in-class oral immuno-oncology agent

GIM-621 is a preclinical stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors.

Read summary →

Labour market · 10/22/2026

Real Diagnostics acquires SimplyTest, expands its high-complexity laboratory portfolio with saliva-based oral health testing

The acquisition adds periodontal health testing to Real Diagnostics' molecular diagnostic laboratory offering for dental providers.

Read summary →

Labour market · 10/22/2026

Tairex launches multi-agent AI system to transform clinical collaboration and decision support

BEIJING, Oct. 22, 2026 — On October 21, Tairex, an AI healthcare technology company incubated by the Institute for AI Industry Research (AIR) at Tsinghua University, unveiled the Multidisciplinary Human- ...

Read summary →